Norris Medicines

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE744C01029
  • NSEID:
  • BSEID: 524414
INR
16.00
0.65 (4.23%)
BSENSE

Aug 11

BSE+NSE Vol: 1.04 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.00",
    "chg": 0.65,
    "chgp": "4.23%",
    "dir": 1,
    "prev_price": "15.35",
    "mcapval": "16.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE744C01029",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "1.04 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines reports standalone net profit of Rs 0.05 crore in the March 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-01 12:08:47",
        "description": "Norris Medicines reports standalone net profit of Rs 0.05 crore in the March 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "210607",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026",
      "datetime": "08-Aug-2026",
      "details": "Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July 2026.",
      "datetime": "30-Jul-2026",
      "details": "Outcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Jul-2026",
      "details": "Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026

08-Aug-2026 | Source : BSE

Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026

Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July 2026.

30-Jul-2026 | Source : BSE

Outcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Announcement under Regulation 30 (LODR)-Change in Management

30-Jul-2026 | Source : BSE

Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available